The Hematology Research Program uses clinical expertise to study various types of blood disease and improve understanding of how normal blood and stem cells become diseased. The Program’s mission is to provide research direction and infrastructure that enables the conduct of investigator-initiated and industry-sponsored clinical trials, translational research, cell banking, cohort studies, registries and quality improvement projects.
Researchers conduct studies with the goal of improving patient care. They investigate therapies and interventions that are likely to benefit patients in terms of disease outcome or quality of life, and facilitate scientific advancement that can lead to cutting-edge discoveries in diagnosis or treatment of blood diseases.
Leukemia, lymphoma, plasma cell dyscrasias and multiple myeloma, marrow failure disorders, hematopoietic stem cell transplantation, thrombosis
10th Floor, 2775 Laurel Street
Vancouver, BC V5Z 1M9